Therapeutic Effect Observation of Tiotropium Bromide in the Treatment of Overlap Syndrome

Authors

  • Yunchao Huang Department of Pulmonary and Critical Care Medicine, The Second People’s Hospital of Yunnan Province
  • Ting Wang The First Affiliated Hospital of Kunming Medical University

DOI:

https://doi.org/10.30564/jams.v3i1.1451

Abstract

Objective: To study the M receptor blocker on inhalation in patients with overlap syndrome (chronic obstructive pulmonary disease and Obstructive sleep apnea syndrome) curative effect analysis. Methods: 25 patients with overlap syndrome as the experimental group, chronic obstructive pulmonary disease patients (30) as control group, patients with overlap syndrome use inhaled tiotropium powder treat 30 days, to observe the changes of pulmonary function, polysomnography, and other indicators after treatment. Results: Overlap syndrome were treated by tiotropium bromide inhalation powder, has improved the pulmonary function, the sleep apnea index and lowest nocturnal oxygen saturation after treatment. Conclusion: tiotropium bromide has a preferable effective in treatment of overlap syndrome, COPD and OSAHS are interacting with each other.

Keywords:

Overlap syndrome, COPD, OSAHS, Tiotropium

References

[1] Weitzenblum E, Chaouat A, Kessler R, et al. The Overlap Syndrome: association of COPD and Obstructive Sleep Apnoea. Rev Mal Respir. 2010 Apr; 27(4):329-40.

[2] Pronzato C. Chronic obstructive pulmonary disease and obstructive sleep apnea. Association, constraints and treatment. Am J Respir Crit Care Med. 2009 Oct 15; 180(8):692-700.

[3] Kim KS, Kim JH, Park SY, et al.Smoking induces oropharyngeal narrowing and increases the severity of obstructive sleep apnea syndrome. J Clin Sleep Med. 2012 Aug 15; 8(4):367-74.

[4] Xianmei Liang. Obstructive sleep apnea syndrome and pulmonary function. Chinese Medical Abstracts, Internal Medicine, 2006, 27(1):24-5. (in Chinese)

[5] Coiiop N. Sleep and sleep disorders in chronic obstructive pulmonary disease. Respiration, 2010, 80(1):78-86.

[6] Drager LF, Bortol otto LA, Loren zi MC, et al. Early signs of atheroscleros is in obstructive sleep apnea[J] . Am J Respir Crit Care Med, 2005, 172(5):613-8.

[7] Yohannes AM, Connolly MJ, Hanania NA.Ten years of tiotropium: clinical impact and patient perspectives. Int J Chron Obstruct Pulmon Dis. 2013; 8:117-25.

[8] Qian Jianmei, Guifang Wang. Research progress of long-acting anticholinergic drug tiotropium. International Journal of Respiratory, 2010, 30(23):1467-9. (in Chinese)

[9] Yunchao Huang, Xiao Li, Ao Liu. Advances in the pathogenesis of obstructive sleep apnea hypopnea syndrome. Journal of Clinical Pulmonary Medicine, 2013, 5(18):898-9. (in Chinese)

[10] Liang Ye, Qingyun Li, Min Li. Advances in research on chronic intermittent hypoxia and sympathetic abnormal excitability. Chinese Journal of Respiratory and Critical Care, 2009, 8(6):609-11. (in Chinese)

[11] Curry DT, Eisenstein RD, Walsh JK. Pharmacologic management of insomnia: past, present, and future[J]. Psychiatr Clin N Am, 2006, 29(4):871-93.

[12] Tatiana D Carvalho, Carlos Marcelo Pastre, et al. Fractal correlation property of heart rate variability in chronic obstructive pulmonary disease. International Journal of COPD 2011; 6:23-28.

[13] Nural S, Gunay E, Halici B, et al. Inflammatory processes and effect of continuous positive airway pressure (CPAP) in overlap syndrome. Inflammationg, 2013136(1):66-74.

Downloads

Issue

Vol. 3 , Iss. 1 (January 2020)

Article Type

Research Article

License

Copyright and Licensing

The authors shall retain the copyright of their work but allow the Publisher to publish, copy, distribute, and convey the work.

Journal of Advances in Medicine Science publishes accepted manuscripts under Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Authors who submit their papers for publication by Journal of Advances in Medicine Science agree to have the CC BY-NC 4.0 license applied to their work, and that anyone is allowed to reuse the article or part of it free of charge for non-commercial use. As long as you follow the license terms and original source is properly cited, anyone may copy, redistribute the material in any medium or format, remix, transform, and build upon the material.

License Policy for Reuse of Third-Party Materials

If a manuscript submitted to the journal contains the materials which are held in copyright by a third-party, authors are responsible for obtaining permissions from the copyright holder to reuse or republish any previously published figures, illustrations, charts, tables, photographs, and text excerpts, etc. When submitting a manuscript, official written proof of permission must be provided and clearly stated in the cover letter.
The editorial office of the journal has the right to reject/retract articles that reuse third-party materials without permission.

Journal Policies on Data Sharing

We encourage authors to share articles published in our journal to other data platforms, but only if it is noted that it has been published in this journal.